Literature DB >> 23639708

Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

Tanya M Laidlaw1, Joshua A Boyce.   

Abstract

Physiologic and pharmacologic studies support the hypothesis that aspirin-exacerbated respiratory disease (AERD) involves fundamental dysregulation in the production of and end-organ responsiveness to both antiinflammatory eicosanoids (prostaglandin E2) and proinflammatory effectors (cysteinyl leukotrienes). The acquired nature of AERD implies a disturbance in a potential epigenetic control mechanism of the relevant mediator systems, which may be a result of incompletely clarified environmental factors (eg, viral or bacterial infections, inhaled pollutants).
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23639708      PMCID： PMC3781366          DOI： 10.1016/j.iac.2012.11.006

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN： 0889-8561            Impact factor:   3.479


  96 in total

1.  The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases.

Authors:  D L DeWitt; E A el-Harith; S A Kraemer; M J Andrews; E F Yao; R L Armstrong; W L Smith
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

2.  The mechanism of LTE4-induced histamine hyperresponsiveness in guinea-pig tracheal and human bronchial smooth muscle, in vitro.

Authors:  C A Jacques; B W Spur; M Johnson; T H Lee
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

3.  Etiology of nasal polyps associated with aspirin-sensitive asthma.

Authors:  T Yamashita; H Tsuji; N Maeda; K Tomoda; T Kumazawa
Journal:  Rhinol Suppl       Date:  1989

4.  Lipoxin formation in human nasal polyps and bronchial tissue.

Authors:  C Edenius; M Kumlin; T Björk; A Anggård; J A Lindgren
Journal:  FEBS Lett       Date:  1990-10-15       Impact factor: 4.124

5.  Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro.

Authors:  C N Serhan; K A Sheppard
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

6.  Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma.

Authors:  J P Arm; S P O'Hickey; B W Spur; T H Lee
Journal:  Am Rev Respir Dis       Date:  1989-07

7.  Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.

Authors:  E A Meade; W L Smith; D L DeWitt
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

8.  Urinary leukotriene E4 in bronchial asthma.

Authors:  C M Smith; R J Hawksworth; F C Thien; P E Christie; T H Lee
Journal:  Eur Respir J       Date:  1992-06       Impact factor: 16.671

9.  Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects.

Authors:  P E Christie; P Tagari; A W Ford-Hutchinson; S Charlesson; P Chee; J P Arm; T H Lee
Journal:  Am Rev Respir Dis       Date:  1991-05

10.  Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.

Authors:  M F Bureau; F De Clerck; J Lefort; C D Arreto; B B Vargaftig
Journal:  J Pharmacol Exp Ther       Date:  1992-02       Impact factor: 4.030
View more
  25 in total

Review 1.  Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Whitney W Stevens; Robert P Schleimer; Robert C Kern
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Jul-Aug

2.  Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors.

Authors:  Tao Liu; Denise Garofalo; Chunli Feng; Juying Lai; Howard Katz; Tanya M Laidlaw; Joshua A Boyce
Journal:  J Immunol       Date:  2015-04-22       Impact factor: 5.422

3.  Biology of nasal polyposis.

Authors:  Whitney W Stevens; Robert P Schleimer; Rakesh K Chandra; Anju T Peters
Journal:  J Allergy Clin Immunol       Date:  2014-05       Impact factor: 10.793

4.  Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.

Authors:  Whitney W Stevens; Christopher J Ocampo; Sergejs Berdnikovs; Masafumi Sakashita; Mahboobeh Mahdavinia; Lydia Suh; Tetsuji Takabayashi; James E Norton; Kathryn E Hulse; David B Conley; Rakesh K Chandra; Bruce K Tan; Anju T Peters; Leslie C Grammer; Atsushi Kato; Kathleen E Harris; Roderick G Carter; Shigeharu Fujieda; Robert C Kern; Robert P Schleimer
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

Review 5.  Eosinophilic and Noneosinophilic Asthma.

Authors:  Tara F Carr; Amir A Zeki; Monica Kraft
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

6.  Comment on: "Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives".

Authors:  İnsu Yılmaz; Murat Türk
Journal:  Drugs       Date:  2017-11       Impact factor: 9.546

7.  Effect of Zileuton Treatment on Sinonasal Quality of Life in Patients with Aspirin-Exacerbated Respiratory Disease.

Authors:  Saangyoung E Lee; Douglas R Farquhar; Katherine N Adams; Maheer M Masood; Brent A Senior; Brian D Thorp; Adam M Zanation; Charles S Ebert
Journal:  Am J Rhinol Allergy       Date:  2019-09-04       Impact factor: 2.467

8.  Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.

Authors:  Whitney W Stevens; Anju T Peters; Annemarie G Hirsch; Cara M Nordberg; Brian S Schwartz; Dione G Mercer; Mahboobeh Mahdavinia; Leslie C Grammer; Kathryn E Hulse; Robert C Kern; Pedro Avila; Robert P Schleimer
Journal:  J Allergy Clin Immunol Pract       Date:  2017-03-09

Review 9.  Pathogenesis of nasal polyposis.

Authors:  K E Hulse; W W Stevens; B K Tan; R P Schleimer
Journal:  Clin Exp Allergy       Date:  2015-02       Impact factor: 5.018

Review 10.  Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease.

Authors:  Maya R Karta; David H Broide; Taylor A Doherty
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.